Insulin aspart. Asp-B28, NovoRapid.
D000818:Animals; D019540:Area Under Curve; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy*; D015507:Drugs, Investigational; D006207:Half-Life; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007328:Insulin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D061267:Insulin Aspart; D014481:United States; D014486:United States Food and Drug Administration
D015507:Drugs, Investigational; D007004:Hypoglycemic Agents; D007328:Insulin; D061267:Insulin Aspart